Edition:
United States

Kangmei Pharmaceutical Co Ltd (600518.SS)

600518.SS on Shanghai Stock Exchange

23.30CNY
20 Jun 2018
Change (% chg)

-- (--)
Prev Close
¥23.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
15,355,415
52-wk High
¥28.25
52-wk Low
¥19.30

Chart for

About

Kangmei Pharmaceutical Co., Ltd is a China-based company, principally engaged in the manufacture and sales of pharmaceutical products. The Company's principal products are Chinese medicines, including American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica and lonicera... (more)

Overall

Beta: 0.87
Market Cap(Mil.): ¥117,093.90
Shares Outstanding(Mil.): 4,974.25
Dividend: 0.23
Yield (%): 0.89

Financials

  600518.SS Industry Sector
P/E (TTM): 26.78 29.73 33.88
EPS (TTM): 0.86 -- --
ROI: 10.84 13.68 13.21
ROE: 14.00 15.46 15.18

BRIEF-Kangmei Pharmaceutical issues 2018 first tranche super short-term financing notes worth 1.5 bln yuan

* Says it issued 2018 first tranche super short-term financing notes worth 1.5 billion yuan, with a term of 270 days and coupon rate of 5.38 percent

Mar 08 2018

BRIEF-Kangmei Pharma Signs Agreement To Set Up Hospital With Partners

* SAYS IT SIGNS AGREEMENT TO INVEST ABOUT 1.08 BILLION YUAN ($165.60 million) TO SET UP HOSPITAL WITH PARTNERS Source text in Chinese: http://bit.ly/2Fk62Wa Further company coverage: ($1 = 6.5216 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Jan 09 2018

BRIEF-Kangmei Pharmaceutical to acquire 80 pct stake in Huizhou-based pharmaceutical firm for 20.8 mln yuan

* Says it plans to acquire 80 percent stake in Huizhou-based pharmaceutical firm for 20.8 million yuan

Dec 29 2017

BRIEF-Kangmei Pharmaceutical to invest 50 mln yuan to set up wholly owned medical appliances firm

* Says its unit will invest 50 million yuan to set up a Beijing-based wholly owned medical appliances firm

Dec 29 2017

Earnings vs. Estimates